Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0104 | 0.4386 | 0.4386 |
Brugia malayi | Melibiase family protein | 0.007 | 0 | 0.5 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.007 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0104 | 0.4386 | 0.4386 |
Schistosoma mansoni | hypothetical protein | 0.0128 | 0.7402 | 0.7402 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0128 | 0.7402 | 1 |
Toxoplasma gondii | melibiase subfamily protein | 0.0104 | 0.4386 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0104 | 0.4386 | 0.4386 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0104 | 0.4386 | 0.4386 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0128 | 0.7402 | 0.5372 |
Schistosoma mansoni | thyroid hormone receptor | 0.0149 | 1 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0149 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.